Literature DB >> 24900734

Histone Deacetylase 4 (HDAC4) Inhibitors: A Promising Treatment for Huntington's Disease.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2013        PMID: 24900734      PMCID: PMC4027504          DOI: 10.1021/ml4002216

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

1.  Histone deacetylase complexes promote trinucleotide repeat expansions.

Authors:  Kim Debacker; Aisling Frizzell; Olive Gleeson; Lucy Kirkham-McCarthy; Tony Mertz; Robert S Lahue
Journal:  PLoS Biol       Date:  2012-02-21       Impact factor: 8.029

2.  Targeting Huntington's disease through histone deacetylases.

Authors:  Steven G Gray
Journal:  Clin Epigenetics       Date:  2011-02-18       Impact factor: 6.551

  2 in total
  1 in total

Review 1.  The nonepigenetic role for small molecule histone deacetylase inhibitors in the regulation of cardiac function.

Authors:  Samantha S Romanick; Bradley S Ferguson
Journal:  Future Med Chem       Date:  2019-06-04       Impact factor: 3.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.